| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.3M | -37.2% |
| SG&A Expense | $4.7M | +10.9% |
| Operating Income | -$12.0M | +24.3% |
| Pre-tax Income | -$9.9M | +38.5% |
| Income Tax | $0 | — |
| Net Income | -$9.9M | +38.5% |
| EPS (Basic) | -$4.12 | +87.7% |
| EPS (Diluted) | -$4.12 | +87.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $3.8M | +24.1% |
| Total Assets | $3.9M | +20.6% |
| Current Liabilities | $3.3M | +72.9% |
| Total Liabilities | $3.7M | +34.2% |
| Stockholders' Equity | $154K | -65.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.6M | +8.3% |
| Financing Cash Flow | $10.7M | +385.5% |